Bayer to acquire Asklepios Bio in foray into gene therapy worth up to $4 bln
By Ludwig BurgerFRANKFURT, Oct 26 (Reuters) - Bayer agreed to acquire unlisted U.S. biotech firm Asklepios BioPharmaceutical Inc for as much as $4 billion...
More from North Carolina Non-Local Sources
NY Times on North Carolina
New Round of 'No Kings' Rallies Focuses on Getting Out the Vote
North Carolina Non-Local Sources
•
3h ago
NY Times on North Carolina
Coastal Storm Threatens Mid-Atlantic With High Winds and Flooding
North Carolina Non-Local Sources
•
7h ago
NY Times on North Carolina
'If Slaughterhouses Had Glass Walls'
North Carolina Non-Local Sources
•
1d ago
NY Times on North Carolina
Trump Returns to Dalton for a Rescue Mission in Georgia
North Carolina Non-Local Sources
•
2d ago
NY Times on North Carolina
These Legislatures Could See Big Changes in November
North Carolina Non-Local Sources
•
3d ago
NY Times on North Carolina
Fact-Checking Senate Ads in Iowa, New Hampshire and North Carolina
North Carolina Non-Local Sources
•
Oct 10, 2026
NY Times on North Carolina
2026 Midterm Elections: Early Vote Tracking in Key Senate Battleground States
North Carolina Non-Local Sources
•
Oct 9, 2026
NY Times on North Carolina
2026 Midterms: How the Battle for the Senate Could Play Out
North Carolina Non-Local Sources
•
Oct 9, 2026